Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies. - Marino M; Rosset F; Nervo A; Piovesan A; Pala V; Vaccaro E; Mastorino L; Calogero AE; Arvat E (Biomedicines, 2025)